[ad_1]
Mesothelioma patients now have a new advanced method to connect mesothelioma treatments around the world – for a price.
Two Harvard-trained oncologists have just rolled out a new app that promises to connect people with cancer as pleural mesothelioma with treatments and clinical trials that even their doctors may not know.
The application, called Driver, is being rolled out this week in the United States and China as a result of a trial with a hundred people over the past year.
How could the driver help mesothelioma patients?
One of the biggest obstacles faced by patients with rare cancers such as the pleura or peritoneal mesothelioma gets the most up-to-date information on potential treatments.
Mesothelioma is a virulent cancer caused by exposure to asbestos. Because it affects only about 2,500 new patients in the United States each year, many oncologists have never seen a case, let alone studied the new experimental treatments of mesothelioma.
Driver aims to help cancer patients, doctors and researchers find all available treatment options for cancers such as mesothelioma, including clinical trials listed with the National Cancer Institute, the leading American cancer research organization.
NCI is a Driver partner with a dozen major cancer hospitals in the United States and has validated its treatment matching system.
"In a world of Amazon, Airbnb and other technology platforms that have revolutionized our ability to access products and services, consumers deserve the same power as the next-generation markets when they do not." They have cancer and need treatment "Polkinghorn, a former radiation oncologist at the Memorial Sloan Kettering Cancer Center.
Using the driver to find new treatments against mesothelioma
To use Driver, mesothelioma patients must download the mobile application and give consent for the platform to acquire its medical records and lab results.
Pilot labs in San Francisco and southern China can analyze patients' tumors, DNA and other data. The application shows them the best treatments and trials for their specific tumors.
"What's missing in this cluttered and noisy ecosystem is something that puts the patient in a nutshell, soup to the nut, and provides them with a complete picture of their options and they'd like to proceed by accessing these options." ", said Petros Giannikopoulos, MD, co-founder of the driver, graduated from Harvard Medical School with Dr. Polkinghorn.
Dr. Giannikopoulos was a pathologist at Harvard when both had the idea of the platform.
The driver may be absent for some mesothelioma patients
Unfortunately, chauffeur services may be inaccessible to many people. mesothelioma patientswho may already be struggling with rising medical costs. The full service, including tumor treatment and registration, treatment matching and referral to specialists, has a single price of $ 3,000 and a monthly fee of $ 20.
Giannikopoulos says that Driver, who is backed by Hong Kong billionaire Li Ka-shing, initially plans to help cover the cost of products for underserved communities. This will not include travel costs if a patient wishes to seek treatment in a remote hospital.
Patients with mesothelioma can find out more about Driver on the company's website at Drive.xyz address.
sources:
Ho, Catherine, "A second opinion on a cancer diagnosis, the comfort of home – at a price", September 5, 2018, San Francisco Chronicle
"Billion-backed Harvard doctors try to reorganize cancer treatment", September 5, 2018, Bloomberg News
Herman, Bob, "How a technology startup wants to connect cancer patients to treatment," September 6, 2018, Axios
Source link
